A baseline increased risk of skin cancers in Rheumatoid arthritis (RA) patients compared to the general population has been reported, with a 40% increase risk of squamous cell carcinoma (SCC) and a 30% relative increase in basal cell carcinoma (BCC), and a further increase in patients receiving TNF inhibitors [1–8]. Here, TNF is linked to rheumatoid arthritis.